| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Quart Barry D is a Chief Executive Officer at HERON THERAPEUTICS, INC. /DE/ with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 14 sells.
Estimated insider holdings value: $921K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 2,800 | $45.00 | $126,000.00 | -10.0% | - | - | |
| Feb 4, 2026 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 15,960 | $45.22 | $721,634.60 | -29.8% | +27.0% | - | |
| Dec 15, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 20,129 | $41.51 | $835,554.79 | -61.6% | +11.9% | - | |
| Jun 11, 2025 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 27,448 | $30.35 | $833,001.36 | -42.2% | +22.0% | - | |
| Nov 29, 2022 | KNSA Kiniksa Pharmaceuticals International, Plc | Director | Sale+OE | 21,959 | $16.15 | $354,637.85 | -100% | -17.2% | -1.7% | |
| Oct 3, 2019 | HRTX Heron Therapeutics, Inc. /de/ | Chief Executive Officer | Buy | 4,571 | $17.50 | $79,992.50 | +5.1% | - | - | |
| Jun 21, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Chief Executive Officer | Sale+OE | 50,000 | $39.05 | $1,952,500.00 | -41.8% | - | - | |
| Mar 19, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Chief Executive Officer | Sale+OE | 100,000 | $29.75 | $2,975,000.00 | -59.5% | - | - | |
| Mar 14, 2018 | HRTX Heron Therapeutics, Inc. /de/ | Chief Executive Officer | Sale+OE | 100,000 | $24.75 | $2,475,000.00 | -59.5% | - | - | |
| Mar 2, 2015 | HRTX Heron Therapeutics, Inc. /de/ | Chief Executive Officer | Sell | 10,000 | $13.07 | $130,727.00 | -18.9% | - | - |